Results of a systematic review of randomised controlled trials of intravitreal bevacizumab for the treatment of diabetic macular oedema (Canadian Agency for Drugs and Technologies in Health)
Diabetes News Service
Results of a systematic review of randomised controlled trials of intravitreal bevacizumab for the treatment of diabetic macular oedema (Canadian Agency for Drugs and Technologies in Health)
For iPhone and iPad | For Android devices
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
Website by Wired up Wales